Earnings Call · Q4 FY2023·2024-02-20

Q4 23EPS -1.64%·Rev n/aQ3 23EPS 0.00%·Rev n/aQ2 23EPS +6.78%·Rev n/aQ1 23EPS +3.92%·Rev n/a⚠ consensus missing

GLOBUS MEDICAL INC GMED

Brian Kearns — Senior Vice President of Business

Daniel Scavilla — President and CEO

Keith Pfeil — Chief Operating and Chief Financial Officer

+3.3%1d on move date+3.3% vs SPY3d+1.8%5d+2.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GMED calls or request research access.

More GMED calls Browse calls Request research access